Santorini Scientific are excited to announce that we recently secured ERDF funding under the KEEP+ programme to work with the University of West England on a Cardiac Diagnostic Project.

Following a heart transplant, a patient’s immune system recognises the new organ as foreign and attempts to reject it.

If rejection occurs, it’s important to detect and monitor it so that treatment can be adjusted overtime. Currently, patients have to undergo an invasive biopsy where a tissue sample is removed from the heart and analysed. However, studies have found that biomarkers of rejection can also be found in the bloodstream.

Santorini Scientific aim to exploit these findings to create a non-invasive technique for measuring rejection and tailoring treatment accordingly.

Our KEEP+ Cardiac Diagnostics Project will determine the feasibility of developing a clinical decision support platform that will harness artificial intelligence (AI) algorithms for monitoring rejection and personalising treatments in heart transplant medicine.

Working in collaboration with the University of the West of England, Santorini Scientific’s exciting new venture will propel forwards the field of precision medicine. If successful, this bold and innovative project will be a stepping-stone towards the individualisation of all medical treatments.